Paul Ryan sold $3.0M of VRT
Chief Procurement Officer at Vertiv Holdings Co. 23,618 shares at an average of $127.24, traded Aug 25, 2025, filed Aug 26, 2025.
Score components
- +15RoleOfficer
- +25Trade size$3.0M at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +9.3%, 3m +32.6%, 6m +98.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950142-25-002273, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 25, 2025 | MOption exercise Class A Common Stock | +2,500 | $9.98 | $25k | 14,203 | Aug 26, 2025 |
| Aug 25, 2025 | SOpen-market sale Class A Common Stock | -1,400 | $125.63 | $176k | 12,803 | Aug 26, 2025 |
| Aug 26, 2025 | MOption exercise Class A Common Stock | +4,445 | $9.98 | $44k | 17,248 | Aug 26, 2025 |
| Aug 26, 2025 | MOption exercise Class A Common Stock | +5,576 | $14.49 | $81k | 22,824 | Aug 26, 2025 |
| Aug 26, 2025 | MOption exercise Class A Common Stock | +6,437 | $15.84 | $102k | 29,261 | Aug 26, 2025 |
| Aug 26, 2025 | MOption exercise Class A Common Stock | +2,500 | $24.87 | $62k | 31,761 | Aug 26, 2025 |
| Aug 26, 2025 | MOption exercise Class A Common Stock | +3,260 | $72.09 | $235k | 35,021 | Aug 26, 2025 |
| Aug 26, 2025 | SOpen-market sale Class A Common Stock | -22,218 | $127.34 | $2.8M | 12,803 | Aug 26, 2025 |
| Aug 25, 2025 | MOption exercise Stock Optionsderivative | -2,500 | $0.00 | $0 | 4,445 | Aug 26, 2025 |
| Aug 26, 2025 | MOption exercise Stock Optionsderivative | -4,445 | $0.00 | $0 | 0 | Aug 26, 2025 |
| Aug 26, 2025 | MOption exercise Stock Optionsderivative | -5,576 | $0.00 | $0 | 1,859 | Aug 26, 2025 |
| Aug 26, 2025 | MOption exercise Stock Optionsderivative | -6,437 | $0.00 | $0 | 6,438 | Aug 26, 2025 |
| Aug 26, 2025 | MOption exercise Stock Optionsderivative | -2,500 | $0.00 | $0 | 21,309 | Aug 26, 2025 |
| Aug 26, 2025 | MOption exercise Stock Optionsderivative | -3,260 | $0.00 | $0 | 9,783 | Aug 26, 2025 |
Related signals
Other insiders at Vertiv Holdings Co and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | Vertiv Holdings Co | Edward L Monser director | $3.9M 15,287 shares | -48% | |
| 40Moderate | Vertiv Holdings Co | Edward L Monser director | $19M 77,294 shares | -82% | |
| 80Strong | Vertiv Holdings Co | David M Cote Executive Chairman | $10M 40,000 shares | -64% | |
| 60Notable | Vertiv Holdings Co | Jan Van Dokkum director | $9.8M 38,647 shares | -61% | |
| 75Notable | Vertiv Holdings Co | Roger Fradin director | $51M 203,333 shares | -186% | |
| 50Moderate | Vertiv Holdings Co | Anders Karlborg EVP, Man., Logistics and Op Ex | $7.5M 30,487 shares | -47% | |
| 75Notable | Vertiv Holdings Co | Steven Reinemund director | $25M 100,000 shares | -75% | |
| 59Moderate | VRTsell Vertiv Holdings Co | Stephen Liang Chief Technology Officer & EVP | $938k 5,501 shares | -58% | |
| 60Notable | Vertiv Holdings Co | Jakki L. Haussler director | $1.9M 15,680 shares | -328% | |
| 65Notable | Vertiv Holdings Co | Steven Reinemund director | $13M 100,000 shares | -43% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.